CIA
BIIB icon

Cohen Investment Advisors’s Biogen BIIB Stock Holding History

Cohen Investment Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-5,674
Closed -$1.97M – 79
2021
Q2 		$1.97M Sell
5,674
-403
-7% -$122K 1.53% 36
2021
Q1 		$1.64M Buy
6,077
+694
+13% +$187K 1.33% 39
2020
Q4 		$1.32M Buy
+5,383
New +$1.39M 1.19% 39

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Cohen Investment Advisors's BIIB Position: Q3 2021 in Review

Cohen Investment Advisors sold out of Biogen (BIIB) in Q3 2021, closing a stake of 5,674 shares — an estimated $1.97M sold.

Cohen Investment Advisors first reported a position in BIIB in Q4 2020 and held it in 3 quarters. The position peaked at $1.97M in Q2 2021. 1,039 funds tracked by Wall St. Rank hold BIIB as of Q3 2021.

  • Cohen Investment Advisors reported no remaining Biogen position as of Q3 2021 after selling out during the quarter.
  • Cohen Investment Advisors sold 5,674 Biogen shares in Q3 2021, an estimated $1.97M.
  • Cohen Investment Advisors first reported a position in Biogen in Q4 2020 and held it in 3 quarters.
  • Cohen Investment Advisors's Biogen position peaked at $1.97M in Q2 2021.
  • 1,039 funds tracked by Wall St. Rank held Biogen as of Q3 2021.

Based on Cohen Investment Advisors's 13F filing for Q3 2021, filed 28 Oct 2021.